CompletedPhase 4

Nexplanon and Combined Oral Contraceptive (COC) Combined Use Study

United States20 participantsStarted 2016-09-15

Plain-language summary

Women currently using or starting a combined oral contraceptive will be offered study enrollment. Study subjects will have a Nexplanon placed and followed for 6 months to evaluate if they continue the COC, continue the implant, or both, and to assess adverse events and bleeding patterns.

Who can participate

Age range16 Years – 35 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion: * Women being seen in a UC Davis medical office or who contact our research office. * Potential participants must be women currently COCs or intending to initiate COCs at the time of the office visit. Exclusion: * Women who have contraindications to using a COC or a contraceptive implant (Category 3 or 4 in the CDC Medical Eligibility Criteria) will be excluded. * Adults unable to consent * Individuals who are not yet adults (infants, children, teenagers) * Pregnant women * Prisoners

What they're measuring

Number of Participants Evaluating ENG as Acceptable: Acceptability (Measurement: Questionnaire)

Timeframe: 6 months

Number of Participants Evaluating ENG as Tolerable: Tolerability (Measurement: Diaries and Questionnaire)

Timeframe: 6 months

Trial details

NCT IDNCT02852265

SponsorUniversity of California, Davis

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2017-07-26

Results submitted2018-03-27

View on ClinicalTrials.gov More Contraception trials